donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CNMD ConMed > Financial Statement > Income statement
CNMD ConMed
100.510
+3.500+3.61%
Post Mkt Price
100.51000.00%
YOY
Do not show
Hide blank lines
(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31
Total revenue
8.63% 277.19M 4.15% 242.33M 17.18% 1.01B 8.36% 273.97M
Operating revenue
8.63% 277.19M 4.15% 242.33M 17.18% 1.01B 8.36% 273.97M
Cost of revenue
10.27% 125.41M 2.02% 106.34M 10.06% 442.6M 0.68% 118.12M
Gross profit
7.32% 151.78M 5.87% 135.99M 23.41% 568.04M 15.01% 155.86M
Operating expense
10.03% 127.32M 4.78% 113.55M 10.63% 458.32M 7.06% 118.64M
Selling and administrative expenses
10.95% 115.83M 4.61% 102.88M 10.95% 414.75M 8.26% 107.28M
Research and development costs
1.55% 11.49M 6.43% 10.67M 7.64% 43.57M -3.03% 11.36M
Operating profit
-4.86% 24.46M 11.76% 22.44M 138.46% 109.72M 50.67% 37.22M
Net non-operating interest income expense
37.07% -5.93M 51.71% -5M 19.45% -35.49M 31.9% -7.57M
Non-operating interest expense
-37.07% 5.93M -51.71% 5M -19.45% 35.49M -31.9% 7.57M
Other net income (expense)
-112.01M -217.46% -1.13M
Gain on sale of security
-- -5.46M -- -- -- -- -- --
Special income (charges)
-- -106.55M -- -- -- -- -- --
-Less:Other special charges
-- 106.55M -- -- -- -- -- --
Other non- operating income (expenses)
-- -- -- -- -217.46% -1.13M -- --
Income before tax
-673.96% -93.48M 79.28% 17.45M 4460.51% 73.11M 119.64% 29.65M
Income tax
2396.16% 74.81M 2015.5% 2.47M 233.47% 10.56M 148.89% 5.2M
Net income
-1366.3% -168.29M 51.88% 14.98M 557.16% 62.54M 1.26% 24.44M
Net income continuous Operations
-1366.3% -168.29M 51.88% 14.98M 557.16% 62.54M 1.26% 24.44M
Minority interest income
Net income attributable to the parent company
-1366.3% -168.29M 51.88% 14.98M 557.16% 62.54M 1.26% 24.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-1366.3% -168.29M 51.88% 14.98M 557.16% 62.54M 1.26% 24.44M
Basic earnings per share
-1328.26% -5.65 50% 0.51 548.48% 2.14 -1.19% 0.83
Diluted earnings per share
-1478.05% -5.65 51.61% 0.47 506.25% 1.94 -7.41% 0.75
Dividend per share
0% 0.2 0% 0.2 0% 0.8 0% 0.2
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
----Unqualified Opinion--

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
CEO: Hartman, Curt R.
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...